Years after his death, the former Apple CEO still wins patents.
Antonio RegaladoFollow @twitterapi
Senior Editor, Business
I am the business editor of MIT Technology Review. I look for stories about how technology is changing business. Before joining MIT Technology Review in July 2011, I lived in São Paulo, Brazil, where I wrote about science, technology, and politics in Latin America for Science and other publications. From 2000 to 2009, I was the science reporter at the Wall Street Journal and later a foreign correspondent.
Antonio Regalado's Stories
They walk among us. Natural experiments, living ordinary lives, unaware that their genes may hold the clue to the next superdrug.
For $25 a year, Google will keep a copy of any genome in the cloud.
Will ultrasound-on-a-chip make medical imaging so cheap that anyone can do it?
The inventor of a breakthrough DNA test for Down syndrome says the technology can be used to screen people for cancer.
If computers think for themselves, should they have human rights?
The FDA ordered 23andMe to stop selling its health tests. But for the intrepid, genome knowledge is still available.
A treatment based on embryonic stem cells clears a key safety hurdle and might help restore vision.
The world’s best-known consciousness researcher says machines could one day become self-aware.
The U.S. announces $46 million to develop new technologies for exploring the brain.